News Galapagos and FibroGen drugs offer hope in IPF Drugs improve on existing medicines from Boehringer and Roche.
News Roche sells rights to troubled asthma and eczema drug Dermira will focus on development in eczema.
News Roche's Tecentriq hits trouble with NICE in bladder cancer Cancer Drugs Fund could cover costs in first line use.
News Roche's Herceptin facing further biosimilar threats in US Breast cancer blockbuster facing potential trio of US competitors.
News Roche raises outlook for 2017 following strong launches The launch of three new products with blockbuster potential helped increase Roche’s revenues 5% in
News Roche joins quest to create closed loop insulin device Partnership will be part of the International Diabetes Closed Loop Trial.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.